Company profile · Kvistgaard, Denmark

Bavarian Nordic

Vaccine Development, Fill-Finish Operations, and Biodefense Manufacturing · Commercial vaccine manufacturing

Commercial-vaccine manufacturing node with live-fill, viral-vaccine scale-up, and biodefence supply relevance for the northern European directory view.

Lead
Paul Chaplin (verified ↗)
Address
Kvistgård, Denmark (source ↗)
Compliance
GMP vaccine manufacturing
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Commercial vaccine manufacturing
Capabilities
Viral Vaccine Manufacturing · Fill-Finish · Commercial Supply Operations
Founded
1994
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Paul Chaplin

President and Chief Executive Officer

Check official leadership source
Full addressKvistgård, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Bavarian Nordic locations page listing Kvistgård as the manufacturing site in Denmark.

Open source
Operating profile

Commercial vaccine manufacturing

Kvistgaard, Denmark. Vaccine Development, Fill-Finish Operations, and Biodefense Manufacturing. Review completed on 14 Mar 2026.

2026 technical specializationVaccine Development, Fill-Finish Operations, and Biodefense Manufacturing
Core capabilities
Viral Vaccine ManufacturingFill-FinishCommercial Supply Operations
Governance

Danish Medicines Agency and global vaccine oversight

GMP vaccine manufacturing, Commercial biologics quality systems

Editorial note

Vaccine Development, Fill-Finish Operations, and Biodefense Manufacturing

Commercial-vaccine manufacturing node with live-fill, viral-vaccine scale-up, and biodefence supply relevance for the northern European directory view.

Editorial note

Bavarian Nordic strengthens the Danish directory layer with a source-backed executive record and a live 2025 annual-report manufacturing profile.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Viral Vaccine Manufacturing
Fill-Finish
Commercial Supply Operations
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBavarian Nordic official leadership page confirming Paul Chaplin as President and CEO.Source origin: bavarian-nordic.comOpen source
Supporting evidenceBavarian Nordic official Annual Report 2025.Source origin: bavarian-nordic.comOpen source
Physical-site evidenceOfficial Bavarian Nordic locations page listing Kvistgård as the manufacturing site in Denmark.Source origin: bavarian-nordic.comOpen source
Infrastructure

Declared infrastructure

Biologics process suites
Aseptic filling lines
Quality-control laboratories
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Bavarian Nordic located?
Bavarian Nordic operates from Kvistgård, Denmark, Kvistgaard, Denmark.
Who runs Bavarian Nordic?
Bavarian Nordic is led by Paul Chaplin, President and Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Bavarian Nordic hold?
Bavarian Nordic is documented under GMP vaccine manufacturing.
What does Bavarian Nordic do?
Commercial-vaccine manufacturing node with live-fill, viral-vaccine scale-up, and biodefence supply relevance for the northern European directory view. Core capabilities: Viral Vaccine Manufacturing, Fill-Finish, Commercial Supply Operations.
Editorial context

Related technical briefs

Briefs that name Kvistgaard as a covered market or city.